date,title,source
Oct-23-18,"Market Trends Toward New Normal in Syros Pharmaceuticals, Westlake Chemical Partners LP, SITO Mobile, ShotSpotter, Motorcar Parts of America, and Benefitfocus  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-25-18,"Syros to Report Third Quarter 2018 Financial Results on Thursday, November 1, 2018",Business Wire
Oct-30-18,Syros to Present Clinical and Preclinical Data on SY-1365 and Earlier-Stage Pipeline at EORTC-NCI-AACR Meeting,Business Wire
Nov-01-18,Edited Transcript of SYRS earnings conference call or presentation 1-Nov-18 11:30am GMT,Thomson Reuters StreetEvents
Nov-01-18,Syros to Present Initial Clinical Data from Combination Cohorts in Its Ongoing Phase 2 Trial of SY-1425 at ASH Annual Meeting,Business Wire
Nov-01-18,Syros Reports Third Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones,Business Wire
Nov-06-18,Edited Transcript of SYRS earnings conference call or presentation 1-Nov-18 11:30am GMT,Thomson Reuters StreetEvents
Nov-07-18,Edited Transcript of SYRS earnings conference call or presentation 1-Nov-18 11:30am GMT,Thomson Reuters StreetEvents
Nov-09-18,Syros Announces Presentation of New Preclinical Data on SY-1365 in Treatment-Resistant HR-Positive Breast Cancer Cell Lines at San Antonio Breast Cancer Symposium,Business Wire
Nov-13-18,Syros Presents New Preclinical Combination Data on SY-1365 and First Preclinical Data from Oral CDK7 Inhibitor Program at EORTC-NCI-AACR Meeting,Business Wire
Nov-15-18,Syros Announces Dose Escalation Data from Phase 1 Trial of SY-1365 Demonstrating Proof-of-Mechanism at Tolerable Doses in Patients with Advanced Solid Tumors,Business Wire
Nov-20-18,Syros to Present at 30th Annual Piper Jaffray Healthcare Conference,Business Wire
Nov-30-18,"Market Trends Toward New Normal in Gartner, CONVERGEONE HLD, Syros Pharmaceuticals, Akers Biosciences, Edge Therapeutics, and Cracker Barrel Old Country Store  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-07-18,Syros Announces New Preclinical Data on SY-1365 at San Antonio Breast Cancer Symposium,Business Wire
Dec-21-18,Syros Added to NASDAQ Biotechnology Index,Business Wire
Feb-05-19,"Analysis: Positioning to Benefit within ArcBest, International Game Technology, eHealth, Syros Pharmaceuticals, La Jolla Pharmaceutical, and Virtus Investment Partners  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Feb-27-19,"Syros to Present New Preclinical Data on Its Selective CDK7 Inhibitors, SY-1365 and SY-5609, at AACR Annual Meeting",Business Wire
Feb-28-19,"Syros to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 7, 2019",Business Wire
Mar-06-19,Syros to Participate in Upcoming Investor Conferences in March,Business Wire
Mar-07-19,"Syros Pharmaceuticals, Inc. (SYRS) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Mar-07-19,Syros Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Multiple Upcoming Clinical Milestones for Its First-in-Class Programs,Business Wire
Mar-12-19,Did You Manage To Avoid Syros Pharmaceuticalss (NASDAQ:SYRS) 47% Share Price Drop?,Simply Wall St.
Mar-13-19,Edited Transcript of SYRS earnings conference call or presentation 7-Mar-19 1:30pm GMT,Thomson Reuters StreetEvents
